AC Immune (ACIU) Earnings Analysis
AC Immune (ACIU) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it beat with EPS -0.19 USD vs -0.2 USD est (+5%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -2.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ACIU next report earnings?
No confirmed upcoming earnings date is currently scheduled for ACIU. This page updates as the calendar is published.
ACIU earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | -0.19 USD | -0.2 USD | +5% | Beat |
| 2026-03-13 | -0.18 USD | -0.19 USD | +5.3% | Beat |
| 2025-04-30 | -0.21 USD | -0.22 USD | +4.5% | Beat |
| 2025-03-13 | -0.18 USD | -0.21 USD | +14.3% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
ACIU valuation and analyst view
| Trailing P/E | -2.80 |
|---|---|
| Trailing EPS | -0.67111 USD |
| Price / book | 5.79 |
| Dividend yield | 0.00% |
| Market cap | 0.22B |
| Analyst consensus | Buy (8 buy / 1 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is AC Immune (ACIU)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ACIU. This page updates as the calendar is published.
Did ACIU beat earnings last quarter?
In its 2026-04-30 report, ACIU posted EPS of -0.19 USD versus a -0.2 USD estimate — a beat of 5%.
What is ACIU's earnings track record?
Over the last 4 reported quarters with consensus data, ACIU beat estimates 4 times (100%).
What is ACIU's current P/E ratio and EPS?
ACIU trades at a trailing P/E of -2.80 on trailing EPS of -0.6711134405483191 USD.
What do analysts rate ACIU?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.